Clinical impact of skeletal muscle mass change during the neoadjuvant chemotherapy period in patients with gastric cancer: An ancillary study of JCOG1002.

Reo SatoMasanori TokunagaJunki MizusawaYuya SatoSeiji ItoDaisuke TakahariTakeshi SanoHiroaki OnayaTakaki YoshikawaNarikazu BokuMasanori Terashima

Published in: World journal of surgery (2023)

Skeletal muscle mass loss occurs frequently during neoadjuvant chemotherapy for locally advanced gastric cancer and could adversely affect survival outcomes.

Keyphrases

neoadjuvant chemotherapy
skeletal muscle
locally advanced
lymph node
sentinel lymph node
insulin resistance
rectal cancer
type diabetes
clinical trial
adipose tissue
study protocol